Greg Went

Greg Went is an experienced entrepreneur and pharmaceutical industry veteran currently serving as the CEO and Chairman of Reflexion Pharmaceuticals since 2021.12 He has a strong background in biotechnology and has founded multiple successful startups in the life sciences.4

Went earned his BS in Chemical Engineering from Carnegie Mellon University in 1985 and his PhD in Chemical Engineering from the University of California, Berkeley in 1990.14

Throughout his career, Greg Went has held several key positions:

1. Co-founder and COO of CuraGen Corporation (1991-1999)4
2. COO and Board Member at DNA Sciences (2000-2001)4
3. Co-founder and Board Member of Tethys Bioscience (2003-2013)4
4. Founder, CEO, and Chairman of Adamas Pharmaceuticals (2004-2019)4
5. Co-founder and Chairman of SynaVir (2020-2022)4

At Reflexion Pharmaceuticals, Went is leading the development of D-protein therapeutics, an entirely new class of drugs that are designed to be extremely specific in targeting while resisting enzymatic breakdown in the body.23

Greg Went is known for his focus on developing innovative medicines that significantly improve patient care, emphasizing the need for products that are "a factor of two to ten times better than the standard of care".23